A multi-institutional grant including the UNC Eshelman School of Pharmacy is helping discover potential treatments for Alzheimer’s disease (AD) while fulfilling the University’s greater mission to expand its neuroscience research efforts. In September 2019, the NIH National Institute on Aging … Read more
The University of North Carolina at Chapel Hill will pursue treatments for specific cancer targets as a specialized member of the National Cancer Institute’s renewed Experimental Therapeutics, or NExT, program through a contract with Leidos Biomed and its Frederick National … Read more
A novel compound developed at the University of North Carolina at Chapel Hill has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the … Read more
In a first-of-its-kind study, researchers at the University of North Carolina at Chapel Hill have discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse the abnormal DNA … Read more
